Any persistent mood symptoms warrant clinical assessment to rule out primary mental health conditions or other medical causes
Yes, patent timelines can change due to legal challenges, patent extensions, or settlements between manufacturers
Caballero-Garca A, Pascual-Fernndez J, Noriega-Gonzlez DC, Bello HJ, Pons-Biescas A, Roche E, et al
Adults With Obesity or Overweight in Clinical Trials A phase 2 obesity trial evaluated once-weekly subcutaneous retatrutide in adults with obesity or overweight without type 2 diabetes and reported substantial dose-dependent reductions in body weight at 24 and 48 weeks [4]
But most importantly these drugs unequivocally reduce the future risk of serious health outcomes, including heart attacks, strokes, death from cardiovascular causes and heart failure symptoms when used long-term, in the two- to five-year window of time, Gerstein said
Employees do not have to wait for HR to find this